The tricyclic antidepressants amitriptyline, nortriptyline and imipramine are weak antagonists of human and rat alpha(1B)-adrenoceptors
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
20/05/2014
20/05/2014
01/07/2010
|
Resumo |
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Processo FAPESP: 08/50423-7 Processo FAPESP: 06/58828 Although it is long known that the tricyclic antidepressants amitriptyline, nortriptyline and imipramine inhibit the noradrenaline transporter and alpha(1)-adrenoceptors with similar affinities, which may lead to self-cancelling actions, the selectivity of these drugs for alpha(1)-adrenoceptor subtypes is unknown. The present study investigates the selectivity of amitriptyline, nortriptyline and imipramine for human recombinant and rat native alpha(1)-adrenoceptor subtypes. The selectivity of amitriptyline, nortriptyline and imipramine was investigated in HEK-293 cells expressing each of the human alpha(1)-subtypes and in rat native receptors from the vas deferens (alpha(1A)), spleen (alpha(1B)) and aorta (alpha(1D)) through [H-3]prazosin binding, and noradrenaline-induced intracellular Ca2+ increases and contraction assays. Amitriptyline, nortriptyline and imipramine showed considerably higher affinities for alpha(1A)- (similar to 25- to 80-fold) and alpha(1D)-adrenoceptors (similar to 10- to 25-fold) than for alpha(1B)-adrenoceptors in both contraction and [H-3]prazosin binding assays with rat native and human receptors, respectively. In addition, amitriptyline, nortriptyline and imipramine were substantially more potent in the inhibition of noradrenaline-induced intracellular Ca2+ increases in HEK-293 cells expressing alpha(1A)- or a truncated version of alpha(1D)-adrenoceptors which traffics more efficiently towards the cell membrane than in cells expressing alpha(1B)-adrenoceptors.Amitriptyline, nortriptyline and imipramine are much weaker antagonists of rat and human alpha(1B)-adrenoceptors than of alpha(1A)- and alpha(1D)-adrenoceptors. The differential affinities for these receptors indicate that the alpha(1)-adrenoceptor subtype which activation is most increased by the augmented noradrenaline availability resultant from the blockade of neuronal reuptake is the alpha(1B)-adrenoceptor. This may be important for the behavioural effects of these drugs. (C) 2010 Elsevier Ltd. All rights reserved. |
Formato |
49-57 |
Identificador |
http://dx.doi.org/10.1016/j.neuropharm.2010.03.015 Neuropharmacology. Oxford: Pergamon-Elsevier B.V. Ltd, v. 59, n. 1-2, p. 49-57, 2010. 0028-3908 http://hdl.handle.net/11449/17522 10.1016/j.neuropharm.2010.03.015 WOS:000279098600006 |
Idioma(s) |
eng |
Publicador |
Pergamon-Elsevier B.V. Ltd |
Relação |
Neuropharmacology |
Direitos |
closedAccess |
Palavras-Chave | #Tricyclic antidepressants #alpha(1)-Adrenoceptor subtypes #Amitriptyline #Nortriptyline #Imipramine |
Tipo |
info:eu-repo/semantics/article |